Efficacy and safety of Etanercept,high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy
Restricted accessOtherFirst published online December, 2006
Efficacy and safety of Etanercept,high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy
We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observed either in clinical symptoms or in laboratory examinations during pregnancy or after delivery. Her autoantibodies except fluorescent anti-nuclear antibodies were negative. We suggest that a combination of anti-TNF-alpha, plasmapheresis and high-dose intravenous gammaglobulin may be a safe and effective therapy for pregnant patients suffering severe lupus nephritis.
Huong DL , Wechsler B , Vauthier-Brouzes D , Beaufils H , Lefebvre G , Piette JC.Pregnancy in the past or present lupus nephritis: a study of 32 pregnancies from a single centre . Ann Rheum Dis2001; 60: 599-604 .
2.
Mintz G , Rodríguez-Alvarez E.Systemic lupus erythematosus . Rheum Dis Clin North Am1989; 15: 257-273 .
3.
Ruiz-Irastorza G , Lima F , Alves Jet al.Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies . Br J Rheumatol1996; 35: 133-138 .
4.
Cortés-Hernández J , Ordi-Ros J , Paredes F , Casellas M , Castillo F , Vilardell-Tarrés M.Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies . Rheumatology (Oxford)2002; 41: 643-650 .
Lockshin MD.Pregnancy does not cause systemic lupus erythematosus to worsen . Arthritis Rheum1989; 32: 665-670 .
7.
Petri M , Howard D , Repke J.Frequency of lupus flare in pregnancy . Arthritis Rheum1991; 34: 1538-1535 .
8.
Ordi-Ros J, Cortés-Hernández J, Vilardell-Tarrés M. [Systemic lupus erythematosus and pregnancy]. In Font J, Khamashta MA, Vilardell M eds. [Systemic lupus erythematosus]. mra ediciones, 2002: 523-537.
9.
Mintz G , Niz j , Gutiérrez G , García-Alonso A , Karchmer S.Prospective study of pregnancy in systemic lupus erythematosus: results of multidisciplinary approach . J Rheumatol1986; 13: 732-740 .
10.
López-Longo FJ , Caro N , Almoguera MIet al.Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage . Lupus2003; 12: 813-819 .
11.
González CM , López-Longo FJ , Vázquez Jet al.Anti-TNF agents are effective and safe in the management of systemic lupus erythematosus (abstract 2127) . Arthritis Rheum2004; 48: S412-S412 .
12.
Urowitz MB , Gladman DD.How to improve morbidity and mortality in systemic lupus erythematosus . Rheumatology (Oxford)2000; 39: 238-244 .
13.
Carreño L , López-Longo FJ , Gonzàlez CM , Monteagudo I.Treatment options for juvenile-onset systemic lupus erythematosus . Pediatr Drugs2002; 4: 241-256 .
14.
Karim MY , Alba P , Cuadrado MJet al.Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents . Rheumatology2002; 41: 876-882 .
15.
Ginzler EM , Dooley MA , Aranow Cet al.Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis . N Engl J Med2005; 353: 2219-2228 .
16.
Strand V.Monoclonal antibodies and other biologic therapies . Lupus2001; 10: 216-221 .
17.
Isenberg D , Leckie MJ.Biological treatments for systemic lupus erythematosus . Scand J Rheumatol2002; 31: 187-191 .
18.
Aringer M , Graninger WB , Steiner G , Smolen JS.Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study . Arthritis Rheum2004; 50: 3161-3169 .
19.
Sills ES , Perloe M , Tucker MJ , Kaplan CR , Palermo GD.Successful ovulation induction, conception and normal delivery alter chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis . Am J Reprod Immunol2001; 46: 366-368 .
20.
Ostensen M , Forger F , Nelson JL , Schuhmacher A , Hebisch G , Villiger PM.Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum . Ann Rheum Dis2005; 64: 839-844 .
21.
Cervera R , Khamashta MA , Font J , Sebastiani GD , Gil A , Lavilla P and the European Working Party on Systemic Lupus Erythematosus . Morbidity and mortality in systemic lupus erythematosus during a 10 year period . Medicine2003; 82: 299-307 .
22.
Tandon A , Ibanez D , Gladman DD , Urowitz MB.The effect of pregnancy on lupus nephritis . Arthritis Rheum2004; 50: 3941-3946 .
23.
Moroni G , Ponticelli C.The risk of pregnancy in patients with lupus nephritis . J Nephrol2003; 16: 161-167 .
24.
Mariani SM , Jolly M.Association of rheumatologic disease with preeclampsia . Obstet Gynecol2004; 104: 1105-1106 .
25.
Dechend R , Gratze P , Wallukat Get al.Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia . Hypertension2005; 45: 742-746 .
26.
Dechend R , Muller DN , Wallukat Get al.Activating auto-antibodies against the AT1 receptor in preeclampsia . Autoimmun Rev2005; 4: 61-65 .
27.
Thomson BJ , Watson ML , Liston WA , Lambie AT.Plasmapheresis in a pregnancy complicated by acute systemic lupus erythematosus. Case report . Br J Obstet1985; 92: 532-534 .
28.
Frampton G , Cameron JS , Thom M , Jones S , Raftery M.Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone . Lancet1987; 2: 1023-1024 .
29.
Lewis EJ , Hunsicker LG , Lan SP , Rohde RD , Lachin JM.A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group . N Engl J Med1992; 326: 1373-1379 .
30.
Lewis EJ.Plasmapheresis in collagen vascular diseases . Ther Apheresis1999; 3: 172-177 .
31.
Carreño L , López-Longo FJ.[Therapeutical apheresis in rheumatic diseases]. In Anaya F ed. [Therapeutical apheresis]. Ediciones Norma-Capitel , 2005: 102-116.
32.
Pasatiempo AM , Kroser JA , Rudnick M , Hoffman BI.Acute renal failure after intravenous immunoglobulin therapy . J Rheumatol1994; 21: 347-349 .
33.
Schroeder JO , Zenner RA , Euler HH , Loffler H.High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and sero-logical results of a pilot study . J Rheumatol1996; 23: 71-75 .
34.
De Pita O , Bellucci AM , Ruffelli M , Girardelli CR , Puddu P.Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus . Lupus1997; 6: 415-417 .
35.
Boletis JN , Ioannidis JP , Boki KA , Moutsopoulos HM.Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis . Lancet1999; 354: 569-570 .
36.
Arahata H , Migita K , Izumoto Het al.Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins . Clin Rheumatol1999; 18: 77-81 .
37.
Levy Y , Sherer Y , Ahmed Aet al.A study of 20 SLE patients with intravenous immunoglobulin: clinical and serologic response . Lupus1999; 8: 705-712 .
38.
Levy Y , Sherer Y , George Jet al.Intravenous immunoglobulin treatment of lupus nephritis . Semin Arthritis Rheum2000; 29: 321-327 .
39.
Moriya Y , Yamaji K , Kanai Y , Tsuda H.The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: a preliminary study . Ther Apher2002; 6: 154-158 .
40.
Welcker M , Helmke K.[Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy] . Immun Infekt1995; 23: 140-141 .
